Novo Patent Fight Over Prandin To Stay In Minn.
The federal judge overseeing Novo Nordisk Inc.'s patent infringement suit against Paddock Laboratories Inc. over diabetes drug Prandin has determined that the U.S. District Court for the District of Minnesota has...To view the full article, register now.
Already a subscriber? Click here to view full article